Received 9 December 2010
In the title compound, C19H12BrFO3S, the 4-fluorophenyl ring makes a dihedral angle of 80.32 (5)° with the mean plane of the naphthofuran fragment. In the crystal, molecules are linked by weak intermolecular C-HO and C-H interactions. The crystal structure also exhibits aromatic - interactions between the central benzene rings of neighbouring molecules [centroid-centroid distance = 3.564 (3) Å].
For the pharmacological activity of naphthofuran compounds, see: Einhorn et al. (1984); Hranjec et al. (2003); Mahadevan & Vaidya (2003). For our previous structural studies of related 1-arylsulfonyl-7-bromo-2-methylnaphtho[2,1-b]furan derivatives, see: Choi et al. (2008a,b).
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 1998); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RK2255 ).
Brandenburg, K. (1998). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2009). APEX2, SADABS and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Choi, H. D., Seo, P. J., Son, B. W. & Lee, U. (2008a). Acta Cryst. E64, o944.
Choi, H. D., Seo, P. J., Son, B. W. & Lee, U. (2008b). Acta Cryst. E64, o1158.
Einhorn, J., Demerseman, P., Royer, R., Cavier, R. & Gayral, P. (1984). Eur. J. Med. Chem. 19, 405-410.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
Hranjec, M., Grdisa, M., Pavelic, K., Boykin, D. W. & Karminski-Zamola, G. (2003). Farmaco, 58, 1319-1324.
Mahadevan, K. M. & Vaidya, V. P. (2003). Indian J. Pharm. Sci. 65, 128-34.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.